Онкология
2366 статей · 70 журналов
Журналы подкатегории (70)
- Blood Neoplasia · Elsevier (100)
- European Journal of Surgical Oncology · Elsevier (95)
- Cancer Treatment and Research Communications · Elsevier (93)
- The Lancet Oncology · Elsevier (93)
- Brachytherapy · Elsevier (91)
- Cancer Epidemiology · Elsevier (90)
- Biochimica et Biophysica Acta: Reviews on Cancer · Elsevier (89)
- International Journal of Gynecological Cancer · Elsevier (88)
- EJC Skin Cancer · Elsevier (85)
- Journal of Thoracic Oncology · Elsevier (84)
- Lung Cancer · Elsevier (77)
- Asia-Pacific Journal of Clinical Oncology · Wiley (76)
- Critical Reviews in Oncology/Hematology · Elsevier (70)
- Urologic Oncology: Seminars and Original Investigations · Elsevier (68)
- Surgical Oncology Clinics of North America · Elsevier (66)
- European Journal of Cancer · Elsevier (65)
- Gynecologic Oncology Reports · Elsevier (65)
- Leukemia Research Reports · Elsevier (65)
- Bulletin du Cancer · Elsevier (59)
- Translational Oncology · Elsevier (59)
- Cancer Letters · Elsevier (57)
- Blood Reviews · Elsevier (54)
- Journal of the National Cancer Center · Elsevier (53)
- Leukemia Research · Elsevier (52)
- The Journal of Liquid Biopsy · Elsevier (52)
- Trends in Cancer · Elsevier (49)
- JACC: CardioOncology · Elsevier (46)
- Surgical Oncology Insight · Elsevier (43)
- Clinical Breast Cancer · Elsevier (40)
- ESMO Open · Elsevier (38)
- Cancer Pathogenesis and Therapy · Elsevier (37)
- Clinical Lung Cancer · Elsevier (33)
- Journal of Geriatric Oncology · Elsevier (30)
- Current Problems in Cancer: Case Reports · Elsevier (29)
- Journal of Bone Oncology · Elsevier (27)
- Precision Radiation Oncology · Wiley (25)
- Intelligent Oncology · Elsevier (19)
- Current Problems in Cancer · Elsevier (17)
- Immuno-Oncology and Technology · Elsevier (16)
- npj Precision Oncology · Springer Nature (12)
- Best Practice & Research Clinical Haematology · Elsevier (11)
- MedComm - Oncology · Wiley (10)
- European Journal of Cancer: Supplement · Elsevier (9)
- Nature Reviews Cancer · Springer Nature (9)
- Nature Reviews Clinical Oncology · Springer Nature (8)
- British Journal of Cancer · Springer Nature (7)
- Cancer Cytopathology · Wiley (5)
- BMC Cancer · Springer Nature (0)
- Breast Cancer Research · Springer Nature (0)
- Breast Cancer Research and Treatment · Springer Nature (0)
- Cancer Cell International · Springer Nature (0)
- Cancer Chemotherapy and Pharmacology · Springer Nature (0)
- Cancer and Metastasis Reviews · Springer Nature (0)
- Cardio-Oncology · Springer Nature (0)
- Cellular Oncology · Springer Nature (0)
- Clinical and Translational Oncology · Springer Nature (0)
- Current Breast Cancer Reports · Springer Nature (0)
- Current Hematologic Malignancy Reports · Springer Nature (0)
- Current Oncology Reports · Springer Nature (0)
- Immuno-Oncology · Springer Nature (0)
- Indian Journal of Gynecologic Oncology · Springer Nature (0)
- Indian Journal of Surgical Oncology · Springer Nature (0)
- Journal of Cancer Research and Clinical Oncology · Springer Nature (0)
- Journal of Gastrointestinal Cancer · Springer Nature (0)
- Journal of Mammary Gland Biology and Neoplasia · Springer Nature (0)
- Journal of the Egyptian National Cancer Institute · Springer Nature (0)
- Molecular Cancer · Springer Nature (0)
- Oncology and Therapy · Springer Nature (0)
- Strahlentherapie und Onkologie · Springer Nature (0)
- best practice onkologie · Springer Nature (0)
- Novel insights into the bone microenvironment in myeloma bone disease
- Comment on “Primary osseous chest wall sarcomas: Oncological and surgical outcomes in a large single-institution cohort of 100 patients”
- Cerebrovascular Accident Risk in Survivors of Head and Neck Cancer: JACC CardioOncology State-of-the-Art Review
- Cardiovascular Toxicity of Antibody-Drug Conjugates in Breast Cancer: Current Evidence and Evolving Considerations: JACC: CardioOncology Primer
- A Simple Clinical Risk Score to Improve Prediction of Anthracycline-Induced Cardiotoxicity
- The Quest for a Safer Use of Anthracyclines Continues: Risk Prediction of Clinical Cardiotoxicity
- Hemoglobin Decline After Oral Anticoagulation Initiation and Subsequent Cancer Detection in Patients With Atrial Fibrillation
- Hemoglobin Decline and Occult Cancer After OAC Initiation: “No Smoke Without Fire?”
- Cardiovascular-Kidney-Metabolic Syndrome Staging and Cancer Risk: Insights From Proteomic and Metabolomic Mediators
- The Cardiometabolic-to-Cancer Axis: Molecular Insights From Cardio-Kidney-Metabolic Syndrome Staging
- Divergent Effects of GnRH Agonist and GnRH Antagonist Treatment on Platelet Activity and Transcriptome
- Do Platelets Explain Why GnRH Antagonists Are Potentially Safer From a Cardiovascular Perspective?
- Sacubitril/Valsartan in Anthracycline-Treated Patients: A Systematic Review and Meta-Analysis of Available Evidence
- Sacubitril/Valsartan and Right Ventricular and Diastolic Function During Breast Cancer Therapy
- A Clinically Applicable Conversion Formula Between NT-proBNP and BNP in Light-Chain Amyloidosis
- Statin Use Attenuates Leuprolide-Associated Coronary Atherosclerosis Progression: A Secondary Analysis of the REVELUTION Trial
- Polygenic Risk Scores for Cardiovascular Risk Prediction in Breast Cancer Survivors: Implications for Asian Populations
- Reply: Polygenic Risk Scores for Cardiovascular Disease in Breast Cancer Survivors: Implications for Asian Populations
- Refining the Prognostic Interpretation of Myocardial PD-L1 Expression in ICI-Associated Myocarditis
- Reply: Refining the Prognostic Interpretation of Myocardial PD-L1 Expression in ICI-Associated Myocarditis
- When “Uptake” Is Organelle Biology: Derisking CRISPR Anthracycline Cardiotoxicity Screens
- Reply: Biochemical Remission and Residual Cardiac Abnormalities in AL Amyloidosis
- Biochemical Remission and Residual Cardiac Abnormalities in AL Amyloidosis
- Identifying Patients With Prostate Cancer Who Benefit Most From Routine Cardiovascular Specialist Referral
- Real-World Cardiotoxicity of Biosimilar versus Reference Trastuzumab in Early HER2-Positive Breast Cancer
- Cardiovascular Considerations of JAK Inhibitors in Patients With Hematologic Malignancies: JACC CardioOncology Primer
- Editorial Board
- Immune Pathways in Doxorubicin Cardiotoxicity: A Cardio-Immunology Perspective: JACC CardioOncology State-of-the-Art Review
- Immune Responses in Checkpoint Inhibitor–Associated Cardiovascular Immune–Related Adverse Events: JACC: CardioOncology State-of-the-Art Review
- Management and Surveillance of Immune Checkpoint Inhibitor Myocarditis: Managing the Aftermath: JACC CardioOncology State-of-the-Art Review